thiophenes has been researched along with Hypertrophy in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Flynn, B; Hua, Y; Huang, L; Kaye, D; Liew, D; Magaye, RR; Reid, C; Savira, F; Wang, BH; Xiong, X | 1 |
Cross, DM; Derzi, M; Horsley, E; Owen, K; Stavros, FL | 1 |
Drexler, W; Findl, O; Heinzl, H; Kiss, B; Petternel, V; Wirtitsch, MG | 1 |
Block, N; Brock, TA; Chen, SJ; Chen, YF; Dixon, RA; Munsch, CL; Sherwood, SJ; Tilton, RG; Wu, C | 1 |
Herndon, RM | 1 |
1 trial(s) available for thiophenes and Hypertrophy
Article | Year |
---|---|
Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.
Topics: Administration, Topical; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cell Count; Cornea; Corneal Diseases; Cross-Over Studies; Double-Blind Method; Endothelium, Corneal; Female; Humans; Hypertrophy; Interferometry; Light; Male; Middle Aged; Sulfonamides; Thiophenes | 2003 |
4 other study(ies) available for thiophenes and Hypertrophy
Article | Year |
---|---|
Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK/STAT signalling and regulation of TIMP1.
Topics: Animals; Animals, Newborn; Biomarkers; Cell Differentiation; Collagen; Fibroblasts; Gene Expression Regulation; Hypertrophy; Janus Kinases; Lysophospholipids; Matrix Metalloproteinase 2; Models, Biological; Myocardium; Myocytes, Cardiac; Oxadiazoles; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Smad2 Protein; Sphingosine; STAT Transcription Factors; Thiophenes; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta | 2020 |
An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (ThelinĀ®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension.
Topics: Alkaline Phosphatase; Animals; Antihypertensive Agents; Blood Coagulation; Carcinogenicity Tests; Carcinogens; Chemical and Drug Induced Liver Injury, Chronic; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Erythrocyte Indices; Female; Hypertension, Pulmonary; Hypertrophy; Isoxazoles; Liver; Liver Function Tests; Male; Mice; Mice, Inbred Strains; Organ Size; Rats; Rats, Sprague-Dawley; Risk Assessment; Species Specificity; Thiophenes | 2012 |
Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy; Hypoxia; Isoxazoles; Male; Monocrotaline; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Thiophenes; Vasoconstriction; Weight Gain | 2000 |
Thiophen induced granule cell necrosis in the rat cerebellum. An electron microscopic study.
Topics: Animals; Cerebellum; Cytoplasmic Granules; Dendrites; Hypertrophy; Microscopy; Microscopy, Electron; Necrosis; Nerve Degeneration; Neuroglia; Neurons; Purkinje Cells; Rats; Synapses; Thiophenes | 1968 |